High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma

Surgical resection represents the only potentially curative therapy for patients with pancreatic adenocarcinoma (PDAC), an aggressive malignancy with a very limited 5-year survival rate. However, even after complete tumor resection, many patients are still facing an unfavorable prognosis underlining...

Descripción completa

Detalles Bibliográficos
Autores principales: Loosen, Sven H, Tacke, Frank, Püthe, Niklas, Binneboesel, Marcel, Wiltberger, Georg, Alizai, Patrick H, Kather, Jakob N, Paffenholz, Pia, Ritz, Thomas, Koch, Alexander, Bergmann, Frank, Trautwein, Christian, Longerich, Thomas, Roderburg, Christoph, Neumann, Ulf P, Luedde, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Cancer Biomarkers and Molecular Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735890/
https://www.ncbi.nlm.nih.gov/pubmed/30805627
http://dx.doi.org/10.1093/carcin/bgz033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735890/
https://www.ncbi.nlm.nih.gov/pubmed/30805627
http://dx.doi.org/10.1093/carcin/bgz033

Ejemplares similares